Etoricoxib 120 mg Film-Coated Tablet

Etoricoxib 120 mg Film-Coated Tablet is a film-coated tablet formulated with 120 mg. The active ingredient profile is Etoricoxib, placing the product in the selective cox-2 nsaid category. The formulation contains an NSAID and/or non-opioid analgesic component intended to reduce pain and inflammatory symptoms when clinically appropriate. The film coating provides a finished oral solid-dosage presentation and may support handling, stability and product acceptability. For website cataloguing, composition, strength, dosage form and release/coating characteristics should be displayed prominently and consistently. The description should remain factual and should not include unapproved cure, superiority, guaranteed-result or broad therapeutic claims. Clinical selection should depend on diagnosis, patient-specific factors, contraindications, concomitant medicines and the prescriber’s judgement. Prescription status, precautions, interactions, adverse effects and dosing must be checked against the current approved product label before publication. Manufacturer, licence, storage, shelf-life, pack configuration and market-specific regulatory details should be added only from verified product documentation.